Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zhulay, T. S."'
Publikováno v:
Clinical pharmacy; Vol. 21 No. 4 (2017); 11-16
Клиническая фармация; Том 21 № 4 (2017); 11-16
Клінічна фармація; Том 21 № 4 (2017); 11-16
Клиническая фармация; Том 21 № 4 (2017); 11-16
Клінічна фармація; Том 21 № 4 (2017); 11-16
It is possible to assume that intranasal forms of drugs with the anti-inflammatory effect (AIE) can be effective for the pathogenic therapy of acute rhinosinusitis (ARS) to relieve nasal congestion.Aim. To determine AIE of Enisamium iodide (EI), asse
Autor:
Zhulay, T. S., Shebeko, S. K.
Publikováno v:
Clinical pharmacy; Vol. 20 No. 3 (2016); 44-48
Клиническая фармация; Том 20 № 3 (2016); 44-48
Клінічна фармація; Том 20 № 3 (2016); 44-48
Клиническая фармация; Том 20 № 3 (2016); 44-48
Клінічна фармація; Том 20 № 3 (2016); 44-48
The basis of the anti-ischemic therapy is a combination of two complementary concepts – hemodynamic and metabolic. They are implemented due to the different mechanisms of drug actions. “Kapikor” medicine was developed by the Latvian scientists.
Publikováno v:
Clinical pharmacy; Vol. 20 No. 1 (2016); 44-48
Клиническая фармация; Том 20 № 1 (2016); 44-48
Клінічна фармація; Том 20 № 1 (2016); 44-48
Клиническая фармация; Том 20 № 1 (2016); 44-48
Клінічна фармація; Том 20 № 1 (2016); 44-48
One of the main reasons in the pathogenesis of chronic ischemia is endothelial dysfunction. Combined use of carnitine precursors and carnitine analogs (Meldonium and γ-butyrobetaine (GBB)) is an interesting decision in terms of optimization of moder